<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02218112</url>
  </required_header>
  <id_info>
    <org_study_id>SNF_ 32003B_149903</org_study_id>
    <nct_id>NCT02218112</nct_id>
  </id_info>
  <brief_title>Impact of Weight Loss After a Bypass Surgery on Renal Hemodynamic Under Stress Conditions</brief_title>
  <acronym>OBBYSS</acronym>
  <official_title>Effect of Weight Loss Induced by a Bypass Surgery on Renal Salt Excretion, Renal Hemodynamic and on Neurohormonal Responses During an Induced Orthostatic Stress in Obese Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The sympathetic nervous (SNS) and the renin angiotensin aldosterone system (RAS) have a&#xD;
      direct impact on renal hemodynamic, hormonal secretion and vasoactive peptide. Many&#xD;
      mechanisms including the SNS, RAS and renal sodium handling could explain the pathogenesis of&#xD;
      hypertension in obese patients. Lifestyle changes and bariatric surgery induce weight loss,&#xD;
      which is associated with blood pressure lowering in obese patients. A diminution in the renal&#xD;
      sympathetic stimulation and RAS activation could explain this effect.&#xD;
&#xD;
      The AIM of this study is to show that weight loss induced by bypass surgery in obese patients&#xD;
      affects renal salt excretion under &quot; low body negative pressure (LBNP)&quot; conditions .&#xD;
&#xD;
      Secondary objectives are to investigate the impact of weight loss on renal hemodynamic&#xD;
      (glomerular filtration rate (GFR), renal plasma flow) and neurohormonal responses under &quot; low&#xD;
      body negative pressure conditions &quot;. We will also analyse renal blood oxygenation with Blood&#xD;
      Oxygenation dependant IRM (BOLD-IRM) technique before and after weight loss.&#xD;
&#xD;
      The population of this study will consist in two groups including 36 patients. The first one&#xD;
      will include 24 obese patients that are going to undergo a bariatric surgery. The second one&#xD;
      will include 12 obese patients without any weight loss associated surgery.&#xD;
&#xD;
      Both group will undergo 3 investigation days. Each patient will have to undergo a screening&#xD;
      visit that will provide dietary advice to ensure a standardized salt intake (120-180&#xD;
      mmol/day) for the duration of the study. The first investigation will define baseline, the&#xD;
      second and third day of investigation will take place after 3 month and 12 month after&#xD;
      bariatric surgery for surgical patients or after baseline for patients without surgery. One&#xD;
      to two weeks before phase 1 and 3 patients will perform a BOLD-MRI. The surgery group will&#xD;
      undergo bariatric surgery between the first investigation phase (baseline) and the second. An&#xD;
      ambulatory blood pressure and 24-hour urine collection will precede each investigation day.&#xD;
      An investigation day consists in renal hemodynamics, neurohormonal and natriuretic response&#xD;
      measurements before, during and after 60 min of LBNP at -30mbar . The duration of the study&#xD;
      per subject is going to take 12 months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2014</start_date>
  <completion_date type="Actual">July 31, 2017</completion_date>
  <primary_completion_date type="Actual">July 31, 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Change in sodium excretion</measure>
    <time_frame>up to one year</time_frame>
    <description>Change in sodium excretion during LBNP conditions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure, renal hemodynamic and neurohormonal response</measure>
    <time_frame>up to one year</time_frame>
    <description>24 hour blood pressure measurement&#xD;
Inulin clearance for GFR measurement&#xD;
Renal plasma flow measured with p-aminohippuric acid (PAH) administration&#xD;
Renin plasmatic activity&#xD;
Aldosterone (plasma)&#xD;
Leptin (plasma)&#xD;
Adiponectin (plasma)&#xD;
Plasmatic and urinary electrolytes&#xD;
Plasmatic and urinary lithium</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">36</enrollment>
  <condition>Obesity</condition>
  <condition>Bariatric Surgery</condition>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>OB - Bariatric surgery (gastric bypass)</arm_group_label>
    <description>Obese patients who will undergo a bariatric surgery (gastric bypass)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OB- Control group</arm_group_label>
    <description>Obese patients who will not undergo surgery - Control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>bariatric surgery (gastric bypass)</intervention_name>
    <arm_group_label>OB - Bariatric surgery (gastric bypass)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient will briefly be informed about the study during their follow-up at the obesity&#xD;
        consultation (Medical Universitary Polyclinic) and the they will be recruited at the&#xD;
        Nephrology center in CHUV (Lausanne).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI &gt;35 Kg/m2&#xD;
&#xD;
          -  Understanding and signing the informed consent&#xD;
&#xD;
          -  Estimated glomerular filtration rate &gt;60 ml/min/1.73 m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute disease&#xD;
&#xD;
          -  Asthma or history of asthma&#xD;
&#xD;
          -  Patient participating in another clinical trial 30 days before the beginning of the&#xD;
             study&#xD;
&#xD;
          -  Blood donation (450ml) 2 months before the beginning of the study&#xD;
&#xD;
          -  Chronic medication which influence renal function (NSAIDS, Others)&#xD;
&#xD;
          -  Allergy&#xD;
&#xD;
          -  Documented renal arterial stenosis&#xD;
&#xD;
          -  History of symptomatic orthostatic hypotension&#xD;
&#xD;
          -  Kidney transplantation&#xD;
&#xD;
          -  Kidney malformation / polycystic kidney disease&#xD;
&#xD;
          -  Impaired judgement&#xD;
&#xD;
          -  Liver failure with ascitis&#xD;
&#xD;
          -  Hip circumference at the upper anterior iliac spine &gt; 130cm&#xD;
&#xD;
          -  Waist circumference &gt;180cm and weighing &gt; 220kg&#xD;
&#xD;
          -  Contraindication/Allergy to furosemide, PAH or Inulin&#xD;
&#xD;
          -  Contraindication to MRI if the patient is going to undergo BOLD-MRI&#xD;
&#xD;
          -  Postprandial glycemia &gt; 11.0 mmol/L in diabetic patients&#xD;
&#xD;
          -  Blood pressure &gt; 180/110 assessed by 24 hour blood pressure measurement&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1004</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <study_first_submitted>August 14, 2014</study_first_submitted>
  <study_first_submitted_qc>August 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2014</study_first_posted>
  <last_update_submitted>March 15, 2018</last_update_submitted>
  <last_update_submitted_qc>March 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Vaudois</investigator_affiliation>
    <investigator_full_name>PD Dr. Gr√©goire Wuerzner</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Blood pressure</keyword>
  <keyword>Obesity</keyword>
  <keyword>Glomerular filtration rate</keyword>
  <keyword>Renal Sodium handling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

